It was bound to happen. With the development of anti retroviral therapies equally successful against HIV, the virus that causes AIDS, the Pharmaceutical industry had to enter the competitive arena of the mercantilisation of AIDS’s treatments and what best than using scary marketing techniques to sale drugs to fight a frightening disease?
Whilst GlaxoSmithKline has been advertising its protease inhibitor Lexiva over the background of a shark infested sea, Bristol-Myers Squibb showed an image of a toilet and says, “Ask your doctor if there are HIV medications with a low risk …